Page 316 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 316

260.e4  Part III  Immunologic Basis of Hematology


        136.  Hawiger D, et al: Dendritic cells induce peripheral T cell unresponsive-  158.  Ochando JC, et al: Alloantigen-presenting plasmacytoid dendritic cells
            ness under steady state conditions in vivo. J Exp Med 194:769–779,   mediate  tolerance  to  vascularized  grafts.  Nat  Immunol  7:652–662,
            2001.                                                 2006. doi: 10.1038/ni1333.
        137.  Probst HC, McCoy K, Okazaki T, et al: Resting dendritic cells induce   159.  Graesser  D,  et al:  Altered  vascular  permeability  and  early  onset  of
                       +
            peripheral  CD8   T  cell  tolerance  through  PD-1  and  CTLA-4.  Nat   experimental  autoimmune  encephalomyelitis  in  PECAM-1-deficient
            Immunol 6:280–286, 2005. doi: 10.1038/ni1165.         mice. J Clin Invest 109:383–392, 2002. doi: 10.1172/JCI13595.
        138.  Grohmann U, Fallarino F, Puccetti P: Tolerance, DCs and tryptophan:   160.  Tada Y, et al: Acceleration of the onset of collagen-induced arthritis by
            much ado about IDO. Trends Immunol 24:242–248, 2003.  a deficiency of platelet endothelial cell adhesion molecule 1. Arthritis
        139.  Mahnke K, et al: The dendritic cell receptor for endocytosis, DEC-205,   Rheum 48:3280–3290, 2003. doi: 10.1002/art.11268.
            can recycle and enhance antigen presentation via major histocompat-  161.  Clement M, et al: CD31 is a key coinhibitory receptor in the devel-
            ibility  complex  class  II-positive  lysosomal  compartments.  J  Cell  Biol   opment  of  immunogenic  dendritic  cells.  Proc  Natl  Acad  Sci  USA
            151:673–684, 2000.                                    111:E1101–E1110, 2014. doi: 10.1073/pnas.1314505111.
        140.  Zlotnikov-Klionsky Y, et al: perforin-positive dendritic cells exhibit an   162.  Zheng J, et al: MicroRNA-23b promotes tolerogenic properties of den-
            immuno-regulatory  role  in  metabolic  syndrome  and  autoimmunity.   dritic cells in vitro through inhibiting Notch1/NF-κB signalling pathways.
            Immunity 43:776–787, 2015. doi: 10.1016/j.immuni.2015.08.015.  Allergy 67:362–370, 2012. doi: 10.1111/j.1398-9995.2011.02776.x.
        141.  Bar-On  L,  Birnberg  T,  Kim  KW,  et al:  Dendritic  cell-restricted   163.  Oderup C, LaJevic M, Butcher EC: Canonical and noncanonical Wnt
            CD80/86  deficiency  results  in  peripheral  regulatory T-cell  reduction   proteins  program  dendritic  cell  responses  for  tolerance.  J  Immunol
            but is not associated with lymphocyte hyperactivation. Eur J Immunol   190:6126–6134, 2013. doi: 10.4049/jimmunol.1203002.
            41:291–298, 2011. doi: 10.1002/eji.201041169.     164.  Kaji R, Kiyoshima-Shibata J, Nagaoka M, et al: Bacterial teichoic acids
        142.  Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell develop-  reverse predominant IL-12 production induced by certain lactobacillus
            ment by the transcription factor Foxp3. Science 299:1057–1061, 2003.   strains into predominant IL-10 production via TLR2-dependent ERK
            doi: 10.1126/science.1079490.                         activation  in  macrophages.  J  Immunol  184:3505–3513,  2010.  doi:
                                            +
        143.  Houot R, Perrot I, Garcia E, et al: Human CD4 CD25 high  regulatory T   10.4049/jimmunol.0901569.
            cells modulate myeloid but not plasmacytoid dendritic cells activation.   165.  Ohnmacht C, et al: Constitutive ablation of dendritic cells breaks self-
            J Immunol 176:5293–5298, 2006.                        tolerance of CD4 T cells and results in spontaneous fatal autoimmunity.
                               +
        144.  Schildknecht A, et al: FoxP3  regulatory T cells essentially contribute   J Exp Med 206:549–559, 2009. doi: 10.1084/jem.20082394.
                         +
            to peripheral CD8  T-cell tolerance induced by steady-state dendritic   166.  Chung  CY,  Ysebaert  D,  Berneman  ZN,  et al:  Dendritic  cells:  cel-
            cells.  Proc  Natl  Acad  Sci  USA  107:199–203,  2010.  doi:  10.1073/  lular  mediators  for  immunological  tolerance.  Clin  Dev  Immunol
            pnas.0910620107.                                      2013:972865, 2013. doi: 10.1155/2013/972865.
        145.  Muth  S,  Schutze  K,  Schild  H,  et al:  Release  of  dendritic  cells  from   167.  Liu  J,  Cao  X:  Regulatory  dendritic  cells  in  autoimmunity:  a  com-
                     +
            cognate CD4  T-cell recognition results in impaired peripheral toler-  prehensive  review.  J  Autoimmun  63:1–12,  2015.  doi:  10.1016/j.
            ance and fatal cytotoxic T-cell mediated autoimmunity. Proc Natl Acad   jaut.2015.07.011.
            Sci USA 109:9059–9064, 2012. doi: 10.1073/pnas.1110620109.  168.  Carreno LJ, Pacheco R, Gutierrez MA, et al: Disease activity in systemic
        146.  Manches O, Fernandez MV, Plumas J, et al: Activation of the nonca-  lupus erythematosus is associated with an altered expression of low-affinity
            nonical NF-κB pathway by HIV controls a dendritic cell immunoregu-  Fc γ receptors and costimulatory molecules on dendritic cells. Immunol-
            latory phenotype. Proc Natl Acad Sci USA 109:14122–14127, 2012.   ogy 128:334–341, 2009. doi: 10.1111/j.1365-2567.2009.03138.x.
            doi: 10.1073/pnas.1204032109.                     169.  Mozaffarian  N,  Wiedeman  AE,  Stevens  AM:  Active  systemic  lupus
        147.  Probst HC, Muth S, Schild H: Regulation of the tolerogenic function   erythematosus  is  associated  with  failure  of  antigen-presenting  cells
            of steady-state DCs. Eur J Immunol 44:927–933, 2014. doi: 10.1002/  to  express  programmed  death  ligand-1.  Rheumatology  (Oxford)
            eji.201343862.                                        47:1335–1341, 2008. doi: 10.1093/rheumatology/ken256.
        148.  Fallarino F, et al: Modulation of tryptophan catabolism by regulatory   170.  Ganguly  D,  Haak  S,  Sisirak  V,  et al:  The  role  of  dendritic  cells  in
            T cells. Nat Immunol 4:1206–1212, 2003. doi: 10.1038/ni1003.  autoimmunity.  Nat  Rev  Immunol  13:566–577,  2013.  doi:  10.1038/
        149.  Liang B, et al: Regulatory T cells inhibit dendritic cells by lymphocyte   nri3477.
            activation gene-3 engagement of MHC class II. J Immunol 180:5916–  171.  Wan S, Zhou Z, Duan B, et al: Direct B cell stimulation by dendritic
            5926, 2008.                                           cells in a mouse model of lupus. Arthritis Rheum 58:1741–1750, 2008.
        150.  Laouar Y, et al: TGF-β signaling in dendritic cells is a prerequisite for   doi: 10.1002/art.23515.
            the control of autoimmune encephalomyelitis. Proc Natl Acad Sci USA   172.  Sang  A,  et al:  Dysregulated  cytokine  production  by  dendritic  cells
            105:10865–10870, 2008. doi: 10.1073/pnas.0805058105.  modulates B cell responses in the NZM2410 mouse model of lupus.
                                                +
                                                     +
        151.  Mahnke K, Qian Y, Knop J, et al: Induction of CD4 /CD25  regula-  PLoS ONE 9:e102151, 2014. doi: 10.1371/journal.pone.0102151.
            tory T cells by targeting of antigens to immature dendritic cells. Blood   173.  Pascual V, Farkas L, Banchereau J: Systemic lupus erythematosus: all
            101:4862–4869, 2003. doi: 10.1182/blood-2002-10-3229.  roads lead to type I interferons. Curr Opin Immunol 18:676–682, 2006.
        152.  Hugues  S,  et al:  Tolerance  to  islet  antigens  and  prevention  from   doi: 10.1016/j.coi.2006.09.014.
            diabetes induced by limited apoptosis of pancreatic β cells. Immunity   174.  Farkas  L,  Beiske  K,  Lund-Johansen  F,  et al:  Plasmacytoid  dendritic
            16:169–181, 2002.                                     cells (natural interferon- α/β-producing cells) accumulate in cutaneous
        153.  Verbovetski I, et al: Opsonization of apoptotic cells by autologous iC3b   lupus erythematosus lesions. Am J Pathol 159:237–243, 2001.
            facilitates  clearance  by  immature  dendritic  cells,  down-regulates  DR   175.  Bennett L, et al: Interferon and granulopoiesis signatures in systemic
            and  CD86,  and  up-regulates  CC  chemokine  receptor  7.  J  Exp  Med   lupus  erythematosus  blood.  J  Exp  Med  197:711–723,  2003.  doi:
            196:1553–1561, 2002.                                  10.1084/jem.20021553.
        154.  Frleta  D,  et al:  HIV-1  infection-induced  apoptotic  microparticles   176.  Blomberg S, et al: Presence of cutaneous interferon-α producing cells
            inhibit human DCs via CD44. J Clin Invest 122:4685–4697, 2012.   in  patients  with  systemic  lupus  erythematosus.  Lupus  10:484–490,
            doi: 10.1172/JCI64439.                                2001.
        155.  Rutella  S,  Danese  S,  Leone  G: Tolerogenic  dendritic  cells:  cytokine   177.  Gilliet M, Cao W, Liu YJ: Plasmacytoid dendritic cells: sensing nucleic
            modulation comes of age. Blood 108:1435–1440, 2006. doi: 10.1182/  acids  in  viral  infection  and  autoimmune  diseases.  Nat  Rev  Immunol
            blood-2006-03-006403.                                 8:594–606, 2008. doi: 10.1038/nri2358.
        156.  Curiel  TJ,  et al:  Blockade  of  B7-H1  improves  myeloid  dendritic   178.  Pettit AR, Thomas R: Dendritic cells: the driving force behind autoim-
            cell-mediated  antitumor  immunity.  Nat  Med  9:562–567,  2003.  doi:   munity in rheumatoid arthritis? Immunol Cell Biol 77:420–427, 1999.
            10.1038/nm863.                                        doi: 10.1046/j.1440-1711.1999.00855.x.
        157.  Wakkach  A,  et al:  Characterization  of  dendritic  cells  that  induce   179.  Ludewig  B,  Odermatt  B,  Landmann  S,  et al:  Dendritic  cells  induce
            tolerance  and  T  regulatory  1  cell  differentiation  in  vivo.  Immunity   autoimmune diabetes and maintain disease via de novo formation of
            18:605–617, 2003.                                     local lymphoid tissue. J Exp Med 188:1493–1501, 1998.
   311   312   313   314   315   316   317   318   319   320   321